SPRY
ARS Pharmaceuticals, Inc
4.10$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 78.9% | 3.9% | 1,300.9% | 243.3% | 23.1% | 24.2% | |
| – | – | 21.1% | 96.1% | -1,200.9% | 100.0% | 76.9% | 75.8% | |
| – | – | 78.9% | 368.2% | 1,396.4% | 67,553.3% | 22.0% | 15.6% | |
| – | – | 23.7% | 85.1% | 1,402.4% | 157,613.3% | 80.4% | 273.1% | |
| – | – | 23.7% | 449.5% | 1,497.9% | 225,166.7% | 80.4% | 288.7% | |
| – | – | -2.6% | -353.3% | -2,698.8% | -225,066.7% | -3.5% | -212.9% | |
| – | – | 0.2% | 1.9% | 63.4% | – | 0.0% | 3.1% | |
| – | – | -6.0% | -367.7% | -2,635.4% | -181,216.7% | 9.3% | -203.3% | |
| – | – | -1.1% | -4.2% | -52.7% | -316.3% | 0.3% | -0.1% | |
| – | – | -6.0% | -367.7% | -2,635.4% | -181,216.7% | 9.0% | -203.3% | |
| – | – | -2.6% | -361.9% | -2,611.2% | -180,973.3% | 9.4% | -198.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.